TIRSA QUARTULLO: Open Payments
NPI 1467455477 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 95 payments from 15 companies in 2025. Trend: 2023 $4,304 · 2024 $2,678 · 2025 $2,493
Food & beverage: $2,398Education: $95
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $647 |
| Galderma Laboratories, L.P. | 12 | $528 |
| LEO Pharma Inc. | 18 | $346 |
| ABBVIE INC. | 17 | $228 |
| UCB, Inc. | 7 | $182 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $142 |
| Janssen Biotech, Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $68 |
| PFIZER INC. | 4 | $66 |
| Arcutis Biotherapeutics, Inc. | 3 | $62 |
Products named: OTEZLA, NEMLUVIO, Bimzelx, ANZUPGO, ADBRY, BOTOX, SKYRIZI, TREMFYA.
Industry payments across AZ — which companies pay providers there.
